Clinical value of TVS-CEUS in diagnosis of early endometrial carcinoma

LIAO Tao; GONG Jinling; FU Chixue

PDF(1530 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2022, Vol. 33 ›› Issue (9) : 751-754.

Clinical value of TVS-CEUS in diagnosis of early endometrial carcinoma

LIAO Tao¹, GONG Jinling², FU Chixue³

Author information +

History +

Abstract

Objective To explore the clinical value of transvaginal sonography contrast-enhanced ultrasonography (TVS-CEUS) in the diagnosis of early endometrial carcinoma.Methods A total of 96 patients with early endometrial adenocarcinoma diagnosed pathologically from March 2016 to October 2021 were selected. All of them underwent transvaginal sonography (TVS), contrast ultrasonography (TS-CEUS) and enhanced magnetic resonance imaging (CEMRI) before surgery. The pathological examination results were used as the gold standard to compare the diagnostic value of the three methods for stage Ia endometrial cancer, and to investigate the consistency of the three examination methods for stage Ia endometrial cancer and pathological results.Results All indicators of TVS-CEUS were significantly higher than those of TVS, and the difference was statistically significant (P＜0.05), while CEMRI and TVS-CEUS showed no significant difference. Kappa test showed that TVS had poor consistency with pathology (Kappa=0.137, P=0.152), and THE Kappa values of TTVS CEUS and MRI were 0.737 and 0.819 respectively, which had fair consistency with pathology (P＜0.01).Conclusions TTVS-CEUS is characterized by high clinical value in differential diagnosis of stage Ia a endometrial carcinoma, which can be used as a preoperative routine examination method.

Key words

transvaginal ultrasound / contrast-enhanced ultrasonography / time-intensity curve;endometrial cancer;early stage

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LIAO Tao, GONG Jinling, FU Chixue. Clinical value of TVS-CEUS in diagnosis of early endometrial carcinoma[J]. Medical Journal of the Chinese People Armed Police Forces. 2022, 33(9): 751-754

References

[1] Marret H, Sauget S, Giraudeau B, et al.Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses[J].Ultrasound Med,2004,23(2): 1629-1639.
[2] Testa A C, Ferrandina G, Fruscella E, et al.The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study[J].Ultrasound Med, 2005, 24(9): 1267-1278.
[3] 袁岚, 高婉仪, 曾永威, 等. 经阴道三维能量多普勒超声检测子宫内膜癌血流与DLL4、 Caveolin-1 表达的相关性研究[J].现代医用影像学, 2016,25(1):1-6.
[4] 王慧.经阴道超声造影诊断子宫内膜病变的临床价值分析[J].实用妇科内分泌杂志, 2017, 4(15):105-107.
[5] Su Q,Sun Z,Lv G. Contrast enhanced ultrasound in diagnosis of endometrial carcinoma and endometrial hyperplasia[J].Cell Mol Biol (Noisy-le-grand),2018, 64(11):88-91.
[6] Green R W, Epstein E. Dynamic contrast-enhanced ultrasound improves diagnostic performancein endometrial cancer staging[J].Ultrasound Obstet Gynecol,2020,56(1):96-105.
[7] 林仲秋.子宫内膜癌诊治指南解读[J].浙江医学, 2015, 37(22):1799-1803.
[8] Epstein E, Van C, Mascilini F,et al. Gray-scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size[J]. Ultrasound Obstet Gynecol, 2011,11(2): 586-593.
[9] Verbakel J Y, Mascilini F, Wynants L, et al. Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (international endometrial tumor analysis)-4 cohort[J].Ultrasound Obstet Gynecol,2020, 1(1): 115-124.
[10] 高天明,付强,丛丽莉,等,醋酸甲地孕酮联合他莫昔芬治疗子宫内膜癌的疗效及其对血清TSGF、PRL、HE4的影响[J]. 武警医学, 2020,31(4):313-316.
[11] 叶丽芬,漆结,张仕铜.超声造影定量分析在围绝经期子宫内膜良恶性疾病鉴别诊断中的价值[J].子宫妇幼保健,2019,3(12):1120-1122.
[12] Sidhu A S, Cantisani V, Dietrich C F, et al. The EFSUMB Guidelines and Recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications[J].Ultraschall Med,2018,39(2):1055-1107.
[13] Testa A C, Ferrandina G, Fruscella E, et al. The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study[J]. Ultrasound Med,2005,24(9):1267-1278.
[14] Liu Y, Tian J W, Xu Y, et al. Role of transvaginal contrast-enhanced ultrasound in the early diagnosis of endometrial carcinoma[J].Chin Med J (Engl), 2012,12(5): 416-421.
[15] Liu Y, Xu Y, Cheng W, et al. Quantitative contrast-enhanced ultrasonography for the differential diagnosis of endometrial hyperplasia and endometrial neoplasms[J].Oncol Lett, 2016,12: 3763-3770.
[16] 朱铖, 周海伟, 郑笑娟, 等. 灰阶超声结合超声造影综合评分在子宫内膜病变诊断中的价值[J]. 中国现代医生,2017,55(7):111-114.
[17] Epstein E, Fischerova D, Valentin L,et al. Ultrasound characteristics of endometrial cancer as defined by international endometrial tumor analysis (IETA) consensus nomenclature: prospective multicenter study[J].Ultrasound Obstet Gynecol,2018,51: 818-828.
[18] Leone F G, Timmerman D, Bourne T, et al. Terms, definitions and measurements to describe the sonographic features of the endometrium and intrauterine lesions: a consensus opinion from the International Endometrial Tumor Analysis (IETA) group[J]. Ultrasound Obstet Gynecol,2010,35: 103-112.
[19] Tang M X, Mulvana H, Gauthier T, et al.Quantitative contrast-enhanced ultrasound imaging: a review of sources of variability[J].Interface Focus,2011,1:520-539.
[20] 张俊莹. 超声造影在早期子宫内膜癌分期诊断中的价值及临床病理特征分析[J].实用癌症杂志,2017, 32(12):2070-2073.
[21] 毛慧, 洪蕾, 贾志莺, 等. 经阴道超声造影评价Ⅰ期子宫内膜癌术前分型的诊断价值[J].肿瘤学杂志,2019, 25(1):71-74.